Paul Loubet

Nimes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications

Hospitalisation and healthcare burden of respiratory syncytial virus in adults aged 50 years and older in France, 2015-2022.

Hospitalisation and healthcare burden of respiratory syncytial virus in adults aged 50 years and older in France, 2015-2022.

Journal: Infectious diseases (London, England)
Published: June 27, 2026

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

Journal: PloS one
Published: May 26, 2026

Cardiovascular Outcomes and Acute Human Metapneumovirus Infection in Adults: A Systematic Literature Review.

Cardiovascular Outcomes and Acute Human Metapneumovirus Infection in Adults: A Systematic Literature Review.

Journal: The Journal of infection
Published: May 13, 2026

Pregnant Women COVID-19 immunisation in 2026: evidence, uncertainty and priorities.

Pregnant Women COVID-19 immunisation in 2026: evidence, uncertainty and priorities.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 04, 2026

PREGNANT WOMEN COVID-19 IMMUNISATION IN 2026: EVIDENCE, UNCERTAINTY AND PRIORITIES.

PREGNANT WOMEN COVID-19 IMMUNISATION IN 2026: EVIDENCE, UNCERTAINTY AND PRIORITIES.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 04, 2026

RSV vaccination in immunocompromised adults.

RSV vaccination in immunocompromised adults.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 19, 2026

mRNA vaccines for multidrug-resistant bacteria: promise, challenges, and microbiome-informed strategies.

mRNA vaccines for multidrug-resistant bacteria: promise, challenges, and microbiome-informed strategies.

Journal: The Lancet. Microbe
Published: March 18, 2026

Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers.

Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: February 11, 2026

Beyond age: comorbidity-informed stratification for RSV hospital outcomes.

Beyond age: comorbidity-informed stratification for RSV hospital outcomes.

Journal: Thorax
Published: February 10, 2026

An evaluation of sipavibart for pre-exposure prophylaxis of COVID-19 in immunocompromised individuals.

An evaluation of sipavibart for pre-exposure prophylaxis of COVID-19 in immunocompromised individuals.

Journal: Expert review of anti-infective therapy
Published: February 06, 2026

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial.

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 28, 2026

Respiratory syncytial virus in adults aged ≥ 50 years in France: a database and time-series modelling analysis (2014-2020).

Respiratory syncytial virus in adults aged ≥ 50 years in France: a database and time-series modelling analysis (2014-2020).

Journal: Infection
Published: January 27, 2026
Showing 1-12 of 157

Last Updated: 09/26/2026